NewEdge Wealth LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 39.4% in the 3rd quarter, Holdings Channel.com reports. The firm owned 35,537 shares of the healthcare conglomerate’s stock after selling 23,130 shares during the period. NewEdge Wealth LLC’s holdings in UnitedHealth Group were worth $11,647,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Studio Investment Management LLC boosted its stake in shares of UnitedHealth Group by 2.7% in the third quarter. Studio Investment Management LLC now owns 7,628 shares of the healthcare conglomerate’s stock valued at $2,634,000 after buying an additional 201 shares during the period. CenterBook Partners LP raised its holdings in UnitedHealth Group by 164.0% in the 3rd quarter. CenterBook Partners LP now owns 10,781 shares of the healthcare conglomerate’s stock valued at $3,723,000 after acquiring an additional 6,697 shares in the last quarter. MJP Associates Inc. ADV grew its holdings in shares of UnitedHealth Group by 30.4% during the 3rd quarter. MJP Associates Inc. ADV now owns 2,208 shares of the healthcare conglomerate’s stock worth $762,000 after purchasing an additional 515 shares in the last quarter. Jacobi Capital Management LLC raised its position in UnitedHealth Group by 16.5% during the third quarter. Jacobi Capital Management LLC now owns 7,046 shares of the healthcare conglomerate’s stock valued at $2,433,000 after purchasing an additional 997 shares in the last quarter. Finally, First National Bank of Omaha acquired a new stake in shares of UnitedHealth Group in the 3rd quarter valued at approximately $1,897,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several research analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price objective for the company. in a report on Wednesday, October 29th. Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating on the stock in a report on Friday, January 30th. Piper Sandler reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. Leerink Partners reduced their price objective on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating for the company in a research report on Wednesday, January 28th. Finally, Morgan Stanley dropped their target price on shares of UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a research report on Friday, January 23rd. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $372.13.
UnitedHealth Group Stock Performance
UNH opened at $288.48 on Thursday. The company has a current ratio of 0.79, a quick ratio of 0.82 and a debt-to-equity ratio of 0.72. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $606.36. The company has a market cap of $261.32 billion, a price-to-earnings ratio of 21.87, a PEG ratio of 1.33 and a beta of 0.41. The company’s fifty day moving average price is $318.83 and its two-hundred day moving average price is $324.13.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. The business had revenue of $113.22 billion during the quarter, compared to the consensus estimate of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The company’s quarterly revenue was up 12.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
About UnitedHealth Group
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Read More
- Five stocks we like better than UnitedHealth Group
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
